Maharashtra budget session curtailed, to begin on March 1

Mumbai (Maharashtra) [India], February 25 (ANI): The budget session of the Maharashtra Assembly has been curtailed...

Pfizer, BioNTech begin testing of third dose against new...

Washington [US], February 25 (ANI): Pfizer and its partner BioNTech on Thursday said that they have begun to test...

IOC to begin 'targeted dialogue' with AOC over their...

Lausanne [Switzerland], February 25 (ANI): The International Olympic Committee (IOC) Executive Board (EB) on...

Sammakka Sarakka Jatara festival begins in Telangana

Mulugu (Telangana) [India], February 25 (ANI): The four-day long traditional festival Sammakka Sarakka Jatara has...

US-Canada to hold first dialogue on climate change by...

Washington [US], February 25 (ANI/Sputnik): The United States and Canada plan to convene the first ministerial...

COVID-19: Plea in Delhi HC seeks directions for Centre to...

New Delhi [India], February 24 (ANI): A plea has been moved in the Delhi High Court seeking direction to the Delhi...

Reconstruction work of 66th school under Indian aid begins in...

Kathmandu [Nepal], February 24 (ANI): The reconstruction work of the 66th school in Nepal, under the Indian grant...

2nd phase of COVID-19 vaccination to begin from March 1;...

New Delhi [India], February 24 (ANI): The second phase of COVID-19 vaccination in India will begin from March ,1...

Ind vs Eng, 3rd Test: Ganguly feels hosts are favourites to...

New Delhi [India], February 24 (ANI): Ahead of the pink-ball Test against England, the Board of Control for...

Ind vs Eng, 3rd Test: Don't see Umesh Yadav in the playing...

New Delhi [India], February 24 (ANI): Former batsman Gautam Gambhir believes that Umesh Yadav will not find a spot...

Counting of votes for Gujarat local body polls to begin soon

Vadodara (Gujarat) [India], February 23 (ANI): Counting of votes polled in elections to six municipal corporations...

Sanofi, GSK start phase 2 trial of their COVID-19 vaccine,...

Paris [France], February 22 (ANI): Sanofi and GlaxoSmithKline (GSK) said on Monday they had begun a phase 2 trial of...